686978 |
FRONTIERS IN ONCOLOGY |
Preoperative Serum Gamma-Glutamyltransferase as a Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer |
2021-05-07 |
10.3389/fonc.2021.648904 |
Su Shiqiang, Liu Lizhe, Sun Chao, Nie Yanhua, Guo Hong, Hu Yang, Guo Shunli, Pang Shujian |
686977 |
FRONTIERS IN ONCOLOGY |
Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung Cancer |
2021-05-07 |
10.3389/fonc.2021.656172 |
Zeng Yangyang, Shi Yingying, Xu Lu, Zeng Yulan, Cui Xiao, Wang Yuan, Yang Ningning, Zhou Fuxiang, Zhou Yunfeng |
686976 |
FRONTIERS IN ONCOLOGY |
Changes in Urologic Operative Practice at the Beginning of the COVID-19 Pandemic in a Large, National Cohort |
2021-05-07 |
10.3389/fonc.2021.684787 |
Lewicki Patrick, Arenas-Gallo Camilo, Basourakos Spyridon P., Punjani Nahid, Venkat Siv, Scherr Douglas S., Hu Jim C., Shoag Jonathan E. |
686975 |
FRONTIERS IN ONCOLOGY |
MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients |
2021-05-07 |
10.3389/fonc.2021.614052 |
Zhang ZhiYuan, Shen LiJun, Wang Yan, Wang Jiazhou, Zhang Hui, Xia Fan, Wan JueFeng, Zhang Zhen |
686974 |
FRONTIERS IN ONCOLOGY |
A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling |
2021-05-07 |
10.3389/fonc.2021.644956 |
Lin Qiu, Luo Li, Wang Hua |
686973 |
FRONTIERS IN ONCOLOGY |
Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances |
2021-05-07 |
10.3389/fonc.2021.671548 |
Chen Run-Ze, Yang Fei, Zhang Min, Sun Zhi-Gang, Zhang Nan |
686972 |
FRONTIERS IN ONCOLOGY |
Cervical Cancer Stem-Like Cell Transcriptome Profiles Predict Response to Chemoradiotherapy |
2021-05-07 |
10.3389/fonc.2021.639339 |
Zuccherato Luciana W., Machado Christina M. T., Magalhães Wagner C. S., Martins Patrícia R., Campos Larissa S., Braga Letícia C., Teixeira-Carvalho Andrea, Martins-Filho Olindo A., Franco Telma M. R. F., Paula Sálua O. C., da Silva Israel Tojal, Drummond Rodrigo, Gollob Kenneth J., Salles Paulo Guilherme O. |
686971 |
FRONTIERS IN ONCOLOGY |
LncRNA SNHG6/miR-125b-5p/BMPR1B Axis: A New Therapeutic Target for Triple-Negative Breast Cancer |
2021-05-07 |
10.3389/fonc.2021.678474 |
Lv Yufei, Lv Xiaohong, Yang Huike, Qi Xiuying, Wang Xiangchen, Li Chao, Shang Xiaochen, Guo Hongmin, Zhang Jianguo, Zhang Yafang |
686970 |
FRONTIERS IN ONCOLOGY |
Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers |
2021-05-07 |
10.3389/fonc.2021.640392 |
Kanno Yuzuka, Chen Chang-Yu, Lee Hsin-Lun, Chiou Jeng-Fong, Chen Yin-Ju |
686969 |
FRONTIERS IN ONCOLOGY |
Targeting DNA Damage Repair for Immune Checkpoint Inhibition: Mechanisms and Potential Clinical Applications |
2021-05-07 |
10.3389/fonc.2021.648687 |
Sun Wei, Zhang Qing, Wang Runkun, Li Yang, Sun Yue, Yang Lin |